| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| 영문 | sympathetic nervous system | 한글 | 교감신경계 |
|---|---|---|---|
| 설명 | 자율신경계의 일종으로 내장기능을 주로 항진시켜 활동을 증가시키는 기능을 가진다. 자율신경계의 다른 계열인 부교감신경계는 반대로 내장기능을 억제시켜 에너지를 비축하는 기능을 가진다. 자율신경계의 해부학적 특성은 신경이 중추신경계에서 나와 목표장기에 도달하기 전에 한번의 시냅스(synapse)를 이룬다는 점이며, 따라서 자율신경계는 두 개의 신경(시냅스를 이루기 전의 절전신경과 이룬 후의 절후신경)으로 구성된다. 자율신경계중 교감신경계는 중추신경계 즉 척수 부근의 교감신경절(sympathetic ganglion)에서 시냅스가 일어나고, 부교감 신경계는 중추신경계에서 멀리 떨어진 목표 장기부근의 신경절(ganglion)에서 시냅스가 일어나는 점이 다르다. |
||
| 영문 | nervous system | 한글 | 신경계 |
|---|---|---|---|
| 설명 | 여러 기관들의 서로간 상호연결체계가 바로 신경계이다. 여기에는 중추신경계(central nerve system: CNS)와 말초신경계(peripheral nerve system: PNS)가 있는데, 중추신경계란 뇌와 척수를 말한다. 그리고 말초신경계에는 12쌍의 뇌신경(cranial nerve: 뇌에서 기시하여 주로 얼굴부위와 목 부위에 분포한다)과 31쌍의 척수신경(spinal nerve:spinal cord에서 각기 양쪽으로 쌍을 이루어 나오는데 주로 목이하부위의 신체 각부분으로 분포하게 된다)으로 구성되어 있다. 또한 말초신경계는 3가지의 신경조직들로 구성되어 있는데 앞에서 말한 뇌신경과 척수신경외에 자율신경계가 여기에 해당된다. 자율신경계는 다시 교감신경과 부교감신경으로 나뉘어져 서로간의 올바른 상호작용으로 생체 여러 가지 작용을 수행한다. |
||
| CC | calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card... |
|---|---|
| PNS | paraneoplastic syndrome; parasympathetic nervous system; partial nonprogressive stroke; peripheral n... |
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OET | oral endotracheal tube; oral esophageal tube |
| BCS | Body condition score |
|---|---|
| C | condition |
| EC | enriched condition |
| SRT | Simple Reaction Time |
| SSLP | Simple Sequence Length Polymorphism |
| runner's condition | <orthopaedics> A condition where the knee cap (patella) rubs on the surface of the femur rather than following its normal tracking over the knee joint. This condition is brought about by stress or overuse (for example runners). Running on hills or incline surfaces can exacerbate this problem. Symptoms include knee pain, just under the knee cap after running, progressing to knee pain at rest. Treatment includes rest and stretching exercises for the quadriceps and hamstring muscles. Strengthening the medial (inner) head of the quadriceps (along the inner thigh) will help pull the knee cap medially and correct the problem. (17 Dec 1997) |
|---|---|
| condition | A mode or state of being, the state of being fit: the physical status of the body as a whole or of one of its parts usually used to indicate abnormality. (18 Nov 1997) |
| sine condition | <microscopy> The design of a lens must fulfill this condition, described by Abbe, if the image is to be aplanatic. It states that the ratio of the sines of the angles of the incident and refracted rays to the axis must be constant, this constant is equal to the inverse of the magnification of the image. (05 Aug 1998) |
| stoichiometric condition | That condition at which the proportion of the air-to-fuel is such that all combustible products will be completely burned with no oxygen remaining in the combustion air. (05 Dec 1998) |
| desired future condition | A vision of the desired future state of a specific area. A description of land and resource conditions expected to result if management goals and objectives are achieved. (05 Dec 1998) |
| disturbed condition | <ecology> Refers to areas in which indicators of one or more characteristics (vegetation, soil and/or hydrology) have been sufficiently altered by man's activities or natural events so as to make it more difficult to recognise whether or not the wetland identification criteria are met. (11 Jan 1998) |
| fibrocystic condition of the breast | A benign disease common in women of the third, fourth, and fifth decades characterised by formation, in one or both breasts, of small cysts containing fluid which may appear as blue dome cysts; associated with stromal fibrosis and with variable degrees of intraductal epithelial hyperplasia and sclerosing adenosis. Synonym: cystic hyperplasia of the breast. (05 Mar 2000) |
| autonomic nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| autonomic nervous system diseases | Diseases that have their major effects on the autonomic nervous system. The autonomic nervous system may be seriously affected in many other disorders including other peripheral nervous system diseases, infectious diseases (e.g., tetanus, diphtheria), immunologic diseases (e.g., acquired immunodeficiency syndrome), and systemic disorders (e.g., diabetic neuropathy, amyloid neuropathy, thyroid diseases). Disorders of central autonomic control also contribute substantially to a wide variety of problems (e.g., eating disorders, panic disorder, water-electrolyte imbalance, cardiovascular diseases). (12 Dec 1998) |
| vegetative nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| ventral nervous system defective | <molecular biology> A Drosophila gene encoding an integral membrane glycoprotein related to amyloidogenic glycoprotein. (12 Jan 1998) |
| parasympathetic nervous system | <anatomy, neurology> One of the two divisions of the vertebrate autonomic nervous sytem. Parasympathetic nerves emerge cranially as pre ganglionic fibres from oculomotor, facial, glossopharyngeal and vagus and from the sacral region of the spinal cord. most neurons are cholinergic and responses are mediated by muscarinic receptors. The parasympathetic system innervates, for example: salivary glands, thoracic and abdominal viscera, bladder and genitalia. Compare:. Sympathetic nervous system. (18 Nov 1997) |
| visceral nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| central nervous system | <anatomy, neurology> Pertaining to the brain, cranial nerves and spinal cord. It does not include muscles or peripheral nerves. In invertebrates, the central nervous system is composed of the segmental ganglia of the ventral nerve cord together with the fused ganglia or brain at the anterior end. Acronym: CNS (12 Jan 1998) |
| central nervous system agents | A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "non-specific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with non-specific mechanisms are generally further classed according to whether they produce behavioural depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|